Ferreira Eliane de Oliveira, de Carvalho Joyce Brito, Peixoto Rafael José M, Lobo Leandro Araujo, Zingalli Russolina B, Smith C Jeffrey, Rocha Edson R, Domingues Regina M C P
Laboratório Biologia de Anaeróbios, Departamento de Microbiologia Médica, UFRJ, Ilha do Fundão, CCS, Instituto de Microbiologia Prof. Paulo de Góes, Rio de Janeiro, Brazil.
FEMS Immunol Med Microbiol. 2009 Jun;56(1):48-55. doi: 10.1111/j.1574-695X.2009.00546.x. Epub 2009 Mar 2.
Bacteroides fragilis is a minor component of the intestinal microbiota and the most frequently isolated from intra-abdominal infections and bacteremia. Previously, our group has shown that molecules involved in laminin-1 (LMN-1) recognition were present in outer membrane protein extracts of B. fragilis MC2 strain. One of these proteins was identified and showed 98% similarity to a putative B. fragilis plasminogen-binding protein precursor, deposited in the public database. Thus, the objective of this work was to overexpress and further characterize this novel adhesin. The ability of B. fragilis MC2 strain and purified protein to convert plasminogen into plasmin was tested. Our results showed that B. fragilis strain MC2 strain adhered to both LMN-1 and plasminogen and this adhesion was inhibited by either LMN-1 or plasminogen. Regarding the plasminogen activation activity, both the whole bacterial cell and the purified protein converted plasminogen into plasmin similar to streptokinase used as a positive control. Bacterial receptors that recognize plasminogen bind to it and enhance its activation, transforming a nonproteolytic bacterium into a proteolytic one. We present in vitro evidence for a pathogenic function of the plasminogen receptor in promoting adherence to laminin and also the formation of plasmin by B. fragilis.
脆弱拟杆菌是肠道微生物群的次要组成部分,也是腹腔内感染和菌血症中最常分离出的细菌。此前,我们小组已表明,参与层粘连蛋白-1(LMN-1)识别的分子存在于脆弱拟杆菌MC2菌株的外膜蛋白提取物中。其中一种蛋白质已被鉴定,与公共数据库中存放的一种假定的脆弱拟杆菌纤溶酶原结合蛋白前体具有98%的相似性。因此,本研究的目的是对这种新型黏附素进行过表达并进一步表征。测试了脆弱拟杆菌MC2菌株和纯化蛋白将纤溶酶原转化为纤溶酶的能力。我们的结果表明,脆弱拟杆菌MC2菌株既能黏附于LMN-1,也能黏附于纤溶酶原,而这种黏附会被LMN-1或纤溶酶原抑制。关于纤溶酶原激活活性,整个细菌细胞和纯化蛋白都能将纤溶酶原转化为纤溶酶,这与用作阳性对照的链激酶相似。识别纤溶酶原的细菌受体与其结合并增强其激活,将一种非蛋白水解细菌转变为蛋白水解细菌。我们提供了体外证据,证明纤溶酶原受体在促进脆弱拟杆菌黏附于层粘连蛋白以及形成纤溶酶方面具有致病功能。